Capricor Therapeutics | CAPR - Assets


Capricor Therapeutics reported $355.95M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Alterity Therapeutics Limited AUD 27.32M 6.07M Jun/2023
Bioline Rx USD 39.8M 3.47M Sep/2025
Capricor Therapeutics USD 355.95M 229.51M Dec/2025
Cipla INR 401.64B 27.77B Sep/2025
Cytokinetics USD 1.42B 12.02M Dec/2025
Geron USD 570.54M 3.16M Dec/2025
Grifols EUR 23.15B 142.7M Dec/2025
Immunic USD 40.7M 20.72M Sep/2025
J&J USD 199.21B 6.39B Dec/2025
Plus Therapeutics USD 11.39M 1.89M Dec/2023
Prothena USD 326.8M 25.82M Dec/2025
PTC Therapeutics USD 2.9B 255.07M Dec/2025
Sarepta Therapeutics USD 3.35B 143.73M Dec/2025